Figure 5
Figure 5. In vivo effect of heparin in mice. (A) Mice were daily treated subcutaneously for 7 days with 50 mg/kg/d UFH and the level of hepatic hepcidin mRNA evaluated by RT-PCR, HRPT1 was used for calibration, the corresponding real-time RT-PCR values were 2% and 2.7% of the control, for the mice treated with 50 mg/kg/d UFH. Bottom: Western blot of the liver homogenates for evaluation of phosphorylated SMAD1/5/8 and of total SMAD5. β-actin was used as load control. The real-time RT-PCR evaluation of Id1 mRNA in the treated mice is shown on the right. (B) Mice were treated subcutaneously for 15 days with the pharmacologic concentration of 2 mg/kg/d UFH or with saline, and liver hepcidin mRNA was evaluated by real-time RT-PCR of in relationship to HPRT1 mRNA. The animals were analyzed for spleen iron and for serum iron concentration. The horizontal bars represent the mean values.

In vivo effect of heparin in mice. (A) Mice were daily treated subcutaneously for 7 days with 50 mg/kg/d UFH and the level of hepatic hepcidin mRNA evaluated by RT-PCR, HRPT1 was used for calibration, the corresponding real-time RT-PCR values were 2% and 2.7% of the control, for the mice treated with 50 mg/kg/d UFH. Bottom: Western blot of the liver homogenates for evaluation of phosphorylated SMAD1/5/8 and of total SMAD5. β-actin was used as load control. The real-time RT-PCR evaluation of Id1 mRNA in the treated mice is shown on the right. (B) Mice were treated subcutaneously for 15 days with the pharmacologic concentration of 2 mg/kg/d UFH or with saline, and liver hepcidin mRNA was evaluated by real-time RT-PCR of in relationship to HPRT1 mRNA. The animals were analyzed for spleen iron and for serum iron concentration. The horizontal bars represent the mean values.

Close Modal

or Create an Account

Close Modal
Close Modal